Is long-term therapy without cyclosporin A (CsA) indispensable or dangerous? One-year results of a prospective randomized trial.
Büsing
M
M
Department of Surgery, University of Tübingen, West Germany.
Hölzer
H
H
Schareck
W D
WD
Mellert
J
J
Greger
B
B
Hopt
U T
UT
Lauchart
W
W
D000961:Antilymphocyte Serum / Q000627:therapeutic use; D001379:Azathioprine / Q000627:therapeutic use*; D002102:Cadaver; D002986:Clinical Trials as Topic; D003524:Cyclosporins / Q000008:administration & dosage / Q000627:therapeutic use*; D004334:Drug Administration Schedule; D004359:Drug Therapy, Combination; D005500:Follow-Up Studies; D006084:Graft Rejection / Q000187:drug effects; D006801:Humans; D016030:Kidney Transplantation; D011239:Prednisolone / Q000627:therapeutic use*; D011446:Prospective Studies; D011897:Random Allocation
D000961:Antilymphocyte Serum; D003524:Cyclosporins; D011239:Prednisolone; D001379:Azathioprine